Opioid Makers Win Major Victory in California Trial
The New York Times
In one of the first cases to be brought against drug manufacturers over the crisis, a judge ruled that there was “simply no evidence” the companies were liable in the epidemic.
Four manufacturers of prescription opioids won the pharmaceutical industry’s first major legal victory in the opioid crisis, turning aside claims by local California governments that they contributed substantially to the epidemic.
In a bench trial decision late Monday, a state judge flatly rejected a legal argument being employed in thousands of cases against the industry over its role in an epidemic of abuse that, according to federal data, has contributed to the deaths of some 500,000 people in the United States since the late 1990s and grown worse during the pandemic.
“There is simply no evidence to show that the rise in prescriptions was not the result of the medically appropriate provision of pain medications to patients in need,” wrote Judge Peter Wilson of Orange County State Superior Court, who presided over a four-month bench trial.
The findings showed the highest mortality occurred among infants who were Black, lived in Southern states or had fetal birth defects.
As Lanzhou beef noodle soup goes from regional specialty to global attraction, I set out to find the best bowls in New York City.
As of Tuesday, 22 children and two adults had been infected, all of whom were unvaccinated, local officials said.
It’s the most energetic particle of its kind ever discovered, and scientists have no idea where it came from.
This 30-minute recipe for “Marry Me Salmon” feels special but is easy enough for a weeknight.
The internet erupted in controversy over Felisa Wolfe-Simon and colleagues’ claim of a microbe thriving on arsenic. Nearly 15 years later, she’s pursuing new research on the boundaries of life.
Once thought of as a byproduct of collard greens, brothy, complex potlikker takes on new life as a wonderful base for a Japanese staple.
The new research adds to the mysteries of the planet’s deepest interior region.
The billionaire is leading a group of investors in the unsolicited offer, which complicates the start-up’s plan to raise more money.
At cardiology conferences and diabetes meetings, doctors can’t help noticing that thin seems to be very in.
President Trump’s executive order is altering scientific exploration across a broad swath of fields, even beyond government agencies, researchers say.
After helping President Trump get elected, Elon Musk was poised to dominate the country’s A.I. policies. Then Mr. Altman sneaked into the White House.
Shock and grief rippled through the health community as lifelines for care were abruptly severed.